DJIA 17,596.35 -350.33 -1.95%
NASDAQ 4,958.47 -122.04 -2.40%
S&P 500 2,057.64 -43.85 -2.09%
market minute promo


23.45 -1.14 (-4.64%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

INSM $23.45 -4.64%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $24.32
Previous Close $24.59
Daily Range $23.40 - $24.58
52-Week Range $11.25 - $25.39
Market Cap $1.4B
P/E Ratio -12.11
Dividend (Yield) $0.00 (0.0%)
Volume 426,176
Average Daily Volume 361,723
Current FY EPS -$2.01




Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website:

News & Commentary

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Use Options For a Chance To Buy INSM at a 62% Discount

Use Options For a Chance To Buy INSM at a 55% Discount

Morning Market Losers

Benzinga's Top #PreMarket Losers

Books-A-Million, HomeAway, Vaalco Energy Lead Monday's After-Hours Movers

Should You Buy Insmed Incorporated Ahead of Earnings? - Tale of the Tape

Use Options For a Chance To Buy INSM at a 52% Discount

Update: Insmed Q3 2014 Earnings

Insmed's (INSM) CEO Bill Lewis on Q3 2014 Results - Earnings Call Transcript

Insmed (INSM) Q3 2014 Results - Earnings Call Webcast

See More INSM News...

INSM's Top Competitors

INSM $23.45 (-4.64%)
Current stock: INSM
AMGN $151.60 (-4.06%)
Current stock: AMGN
GILD $115.46 (-3.38%)
Current stock: GILD
BIIB $396.21 (-3.06%)
Current stock: BIIB